Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Serum Levels of Insulin- Like Growth Factor and Fertility

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2006 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
Information provided by:
Hadassah Medical Organization Identifier:
First received: August 14, 2006
Last updated: NA
Last verified: August 2006
History: No changes posted
this study will try to determine whether serum levels of insulin like growth factor are higher in fertile women than infertile women.

Condition Phase
Phase 0

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: Serum Levels of Insulin-Like Growth Factor in Fertile and Infertile Women Over 40 Years Old

Further study details as provided by Hadassah Medical Organization:

Estimated Enrollment: 60
Study Start Date: January 2007
Estimated Study Completion Date: December 2007
Detailed Description:
this study will try to determine whether serum levels of insulin like growth factor are higher in fertile women than infertile women.The women will over 40 years old.

Ages Eligible for Study:   40 Years to 55 Years   (Adult)
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • 40-55 years old
  • healthy

Exclusion Criteria:

  • pregnant women
  • breast feeding
  • menopause
  • vegetarian
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00364507

Sponsors and Collaborators
Hadassah Medical Organization
Study Chair: David MANKUTA, MD Hadassah Medical Orginization
  More Information Identifier: NCT00364507     History of Changes
Other Study ID Numbers: IGF1-HMO-CTIL 
Study First Received: August 14, 2006
Last Updated: August 14, 2006
Health Authority: Israel: Ethics Commission

Additional relevant MeSH terms:
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action processed this record on January 18, 2017